Dyadic International Inc

DYAI

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001213809

SEC filings (opens in a new tab)

In the last 90 days, Dyadic International Inc insiders filed 0 open-market purchases and 2 sales; 39 institutions reported holding it in 13F filings for Q2 2026, worth $4.14M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Dyadic International Inc changed between Q2 2022 and Q3 2022.

All holders in Q3 2022 All holders in Q2 2022

13F holders of DYAI: Q2 2022 compared with Q3 2022
Measure	Q2 2022	Q3 2022	Change
Holders	33	34	+1
Shares	3.79M	3.74M	−51.0K (−1.3%)
Value	$11.6M	$7.14M	−$4.42M (−38.2%)

New holders (2)

Institutions that held Dyadic International Inc at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to DYAI in Q3 2022
Institution	Shares	Value	% of portfolio
Susquehanna Fundamental Investments, LLC	12,462	$24.0K	0.00%
Tower Research Capital LLC (TRC)	11,615	$22.0K	0.00%

Sold out (1)

Institutions that held Dyadic International Inc at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of DYAI in Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
Teramo Advisors, LLC	10,000	$31.0K